Research programme: traditional Chinese medicinal therapeutics - Chipscreen
Alternative Names: CS 900210; CS 90034602; CS 90050105; CS 90060103Latest Information Update: 15 Aug 2007
At a glance
- Originator Chipscreen Biosciences
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia; Cancer; Osteoporosis; Type 2 diabetes mellitus
Most Recent Events
- 20 Jul 2004 Preclinical trials in Benign prostatic hyperplasia in China (unspecified route)
- 20 Jul 2004 Preclinical trials in Cancer in China (unspecified route)
- 20 Jul 2004 Preclinical trials in Osteoporosis in China (unspecified route)